Related Experiment Video
Updated: Jul 19, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
A comparison of three different models for estimating relative risk in meta-analysis of clinical trials under
Ronny Kuhnert1, Dankmar Böhning
1Division for International Health and Biometry, Institute for Social Medicine, Epidemiology, and Health Economy, Joint Centre for Health Sciences and Humanities, Charité Medical School Berlin, Fabeckstr. 60-62, 14195 Berlin, Germany. kuhnertr@rki.de
Abstract:
We focus on the comparison of three statistical models used to estimate the treatment effect in meta-analysis when individually pooled data are available. The models are two conventional models, namely a multi-level and a model based upon an approximate likelihood, and a newly developed model, the profile likelihood model which might be viewed as an extension of the Mantel-Haenszel approach. To exemplify these methods, we use results from a meta-analysis of 22 trials to prevent respiratory tract infections. We show that by using the multi-level approach, in the case of baseline heterogeneity, the number of clusters or components is considerably over-estimated. The approximate and profile likelihood method showed nearly the same pattern for the treatment effect distribution. To provide more evidence two simulation studies are accomplished. The profile likelihood can be considered as a clear alternative to the approximate likelihood model. In the case of strong baseline heterogeneity, the profile likelihood method shows superior behaviour when compared with the multi-level model.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Relative Risk
Mechanistic Models: Compartment Models in Individual and Population Analysis
Hazard Ratio
For example, in a clinical trial evaluating a...
Bioequivalence Data: Statistical Interpretation